Recent advancements in mass spectrometry and computational tools enhance the feasibility of top-down proteomics. Top-down ...

Researchers at Duke University used CRISPR technologies to discover previously unannotated stretches of DNA in the "dark ...

Scientists developed a new nanostructure that triples CRISPR’s ability to enter cells, unlocking even more power to treat ...

I cried with every single patient,” Sung says. “It just was this crazy feeling that, for the patients and families, almost can’t feel real.” The treatment, known as AMT-130, is delivered deep into the ...

After years of heartbreak, researchers have found an experimental treatment that can slow the progression of Huntington’s ...

RetinalGenix Technologies Inc. (OTCQB:RTGN) ('RetinalGenix” or the 'Company”), a pioneering developmental-stage ophthalmic ...

Biotech company Factor Bioscience sued rival Cellectis and pharmaceutical giant AstraZeneca in Delaware federal court on ...

Scientists are exploring how RNA might have jump-started life four billion years ago and how it's now advancing drug ...

RetinalGenix Technologies advances patent portfolio to monitor ocular and systemic disease care: Apollo Beach, Florida Saturday, September 27, 2025, 13:00 Hrs [IST] RetinalGenix T ...

The Slovak Academy of Sciences (SAV) published a long-awaited report on the composition of Covid-19 vaccines, a renowned ...

This important study demonstrates that ocular organoids can generate both retina and lens through a non-canonical, "inside-out" morphogenetic route. The work is solid, with well-designed experiments ...

Biotech firm Factor Bioscience has filed a lawsuit against Cellectis and AstraZeneca, accusing the companies of allegedly ...